Uploaded on May 17, 2024
According to the latest research report by IMARC Group, The global immunity boosting products market size reached US$ 27.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 52.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.57% during 2024-2032. More Info:- https://www.imarcgroup.com/immunity-boosting-products-market
Immunity Boosting Products Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
Global Immunity Boosting
Products Market
Research and Forecast
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved
About IMARC Group
In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management
s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry
vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and
t ransform thei r bus inesses.
IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological
developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology
organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls ,
chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods
are at the top of the company’s exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and
markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients
achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure
las t ing resul ts .
Acco r d ing t o t h e l a t es t r epo r t by I M A RC G r o up , t i t l e d " I mm uni t y Bo ost i ng
Prod uct s M arke t : G l oba l I ndus t ry T re nds , Sha re , S i ze , G ro w t h , O ppor t un i t y and
For ec as t 202 4 - 203 2 , " t h e g lob a l i m m u n i t y b oos t i n g p r oduc t s m a r ke t s i ze r each ed
US$ 27 . 3 B i l l i on i n 20 23 .
I m m un i t y bo os t i ng p r oduc t s r e f e r t o t he va r i ous f ood p r odu c t s t ha t poss ess im m u ne-
Report m od u la t o r y p r ope r t i es a nd o f f e r spe c i f i c and non - spec i f i c i m m u ne r esp onses . Th e i r
con sum pt ion a id s i n bo os t i ng t h e im m un i t y o f i nd i v idua ls wh i l e m in im iz ing n u t r i t i o na l
Highlight and de f i c i enc ie s .
W ide l y con s i s t i n g o f p r o b io t i c s , p r eb i o t i c s , d ie t a r y supp le m en t s and o t h e r f oo d a nd
bev er age p r od uc t s , t he se co nsu m ab le s a r e a r i ch so u r ce o f f i b e r s , m ine r a l s ,
Description enz ym es , v i t a m ins , a m ino ac ids , an d m ic r o and m ac r onu t r i en t s . They a r e an
esse n t i a l com pone n t o f im m u n i t y ca r e and p r ev en t i ve h ea l t h ca r e as t he i r r egu la r
con sum pt ion ass i s t s t he hum an bod y f i g h t aga in s t num er ous i n f ec t i o ns and v i r u ses
i n a n e f f i c i en t m ann e r .
Reque st f o r a PDF sam pl e o f t h i s re por t :
h t t p s : / / www. im ar c g r ou p . com / im m un i t y - boo s t i ng - p r o duc t s - m ar ke t / r eque s t sam p le
Report Description
G l o b a l I m m u n i t y B o o s t i n g P r o d u c t s M a r k e t T r e n d s :
T h e g l o b a l m a r k e t i s p r i m a r i l y d r i v e n b y t h e g r o w i n g c o n s c i o u s n e s s r e g a r d i n g h e a l t h a n d w e l l n e s s a m o n g i n d i v i d u a l s . W i t h t h e h e c t i c
l i f e s t y l e l e d b y t h e w o r k i n g p o p u l a t i o n , u n t i m e l y c o n s u m p t i o n o f m e a l s , r i s i n g p r e f e r e n c e f o r s m o k i n g a n d c o n s u m i n g a l c o h o l a n d a l a c k
o f p h y s i c a l a c t i v i t i e s a r e b e c o m i n g i n c r e a s i n g l y p r e v a l e n t a m o n g t h e m a s s e s . T h i s h a s r e s u l t e d i n w e a k e n i n g t h e i r i m m u n e s y s t e m s
t h a t , i n t u r n , c a n a d v e r s e l y a f f e c t t h e i r h e a l t h . I n o r d e r t o i m p r o v e t h e m e t a b o l i s m r a t e o f t h e b o d y a n d p r e v e n t i n c i d e n c e s o f c h r o n i c
l i f e s t y l e d i s e a s e s , i n d i v i d u a l s a r e n o w p r e f e r r i n g t o c o n s u m e i m m u n i t y b o o s t i n g p r o d u c t s o n a r e g u l a r b a s i s a s a p r e v e n t i v e m e a s u r e ,
t h e r e b y p r o v i d i n g a t h r u s t t o t h e m a r k e t g r o w t h . A l o n g w i t h t h i s , t h e i n c r e a s i n g g e r i a t r i c p o p u l a t i o n a n d t h e h i g h o c c u r r e n c e o f c h r o n i c
i l l n e s s e s a m o n g t h e m a r e a l s o d r i v i n g t h e g r o w t h o f t h e m a r k e t . T h e m a r k e t i s f u r t h e r d r i v e n b y t h e r a p i d o u t b r e a k o f g l o b a l e p i d e m i c s
a n d p a n d e m i c s a c r o s s t h e g l o b e i n r e c e n t y e a r s . T h e c u r r e n t s t a t e p e r t a i n i n g t o t h e e v e r - i n c r e a s i n g n u m b e r o f p a t i e n t s s u f f e r i n g f r o m
c o r o n a v i r u s d i s e a s e s ( C O V I D - 1 9 ) h a s l e d t h e m a j o r i t y o f t h e u n a f f e c t e d p o p u l a t i o n t o c o n s u m e i m m u n i t y b o o s t i n g f o o d s i n a n a t t e m p t
t o p r o t e c t t h e i r b o d y f r o m b e i n g i n f e c t e d b y t h e v i r u s . N u m e r o u s o r g a n i z a t i o n s a r e a l s o u n d e r t a k i n g i n i t i a t i v e s t o s p r e a d a w a r e n e s s
r e g a r d i n g t h e i m p o r t a n c e o f m a i n t a i n i n g h i g h i m m u n i t y a m i d s t t h e p a n d e m i c , w h i c h h a s b e e n i n s t r u m e n t a l i n c o n t r i b u t i n g t o t h e m a r k e t
g r o w t h . S o m e o f t h e o t h e r f a c t o r s c a t a l y z i n g t h e m a r k e t g r o w t h i n c l u d e h i g h i n v e s t m e n t s i n r e s e a r c h a n d d e v e l o p m e n t a n d t h e a d v e n t
o f o r g a n i c a n d n o n - g e n e t i c a l l y m o d i f i e d o r g a n i s m s ( G M O ) h e a l t h s u p p l e m e n t s a v a i l a b l e i n t h e f o r m o f f l a v o r - e n h a n c e d g u m m i e s , s o f t
g e l s a n d p i l l s .
V i e w R e p o r t T O C , F i g u r e s a n d T a b l e s : h t t p s : / / w w w . i m a r c g r o u p . c o m / i m m u n i t y - b o o s t i n g - p r o d u c t s - m a r k e t
Breakup by Type:
• Supplements
• Beverages
• Food
o Nuts and Seeds
o Fruits and Vegetables
Report o Dairy-based Products
o Probiot ics and Prebiot ics
Segmentation o Others
• Others
Breakup by Distribution Channel:
• Convenience Stores
• Medical Stores
• Supermarkets and Hypermarkets
• Online Stores
• Others
Breakup by Region:
• North America
•
Report Asia-Pacifi c
• Europe
Segmentation • Latin America
• Middle East and Afr ica
• Associated Brit ish Foods Plc
• Danone S.A.
• Diamond Foods (Snyder's-Lance Inc.)
Competitive • Dole Food Company
Landscape • Fonterra group Cooperative Limited
• Hines Nut Company
with Key
• Nestle S.A.
Players • Olam International
• Pinnacle Foods (Conagra Brands Inc.) .
How has the global immunity boosting products market
performed so far, and how will it perform in the coming
years?
What are the drivers, restraints, and opportunities in
the global immunity boosting products market?
Key What is the impact of each driver, restraint, and opportunity on the global immunity boosting products
market?
Questions
Answered in What are the key regional markets?
the Report
Which countries represent the most attractive
immunity boosting products market?
What is the breakup of the market based on the type?
Which is the most attractive type in the immunity
boosting products market?
What is the breakup of the market based on the
distribution channel?
Which is the most attractive distribution channel in the
immunity boosting products market?
Key
What is the competitive structure of the global
immunity boosting products market?
Questions
Answered in Who are the key players/companies in the global
immunity boosting products market?
the Report
1 P r e f a c e
2 S c o p e a n d M e t h o d o l o g y
2 . 1 O b j e c t i v e s o f t h e S t u d y
2 . 2 S t a k e h o l d e r s
2 . 3 D a t a S o u r c e s
2 . 3 . 1 P r i m a r y S o u r c e s
2 . 3 . 2 S e c o n d a r y S o u r c e s
2 . 4 M a r k e t E s t i m a t i o n
2 . 4 . 1 B o t t o m - U p A p p r o a c h
Table of 2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y
3 E x e c u t i v e S u m m a r y
4 I n t r o d u c t i o n
4 . 1 O v e r v i e w
Contents 4 . 2 K e y I n d u s t r y T r e n d s5 G l o b a l I m m u n i t y B o o s t i n g P r o d u c t s M a r k e t 5 . 1 M a r k e t O v e r v i e w
5 . 2 M a r k e t P e r f o r m a n c e
5 . 3 I m p a c t o f C O V I D - 1 9
5 . 4 M a r k e t F o r e c a s t
6 M a r k e t B r e a k u p b y Ty p e
6 . 1 S u p p l e m e n t s
6 . 1 . 1 M a r k e t Tr e n d s
6 . 1 . 2 M a r k e t F o r e c a s t
6 . 2 B e v e r a g e
6 . 2 . 1 M a r k e t Tr e n d s
6 . 2 . 2 M a r k e t F o r e c a s t
6 . 3 F o o d
6 . 3 . 1 M a r k e t Tr e n d s
6 . 3 . 2 M a j o r Ty p e s
6 . 3 . 2 . 1 N u t s a n d S e e d s
6 . 3 . 2 . 2 F r u i t s a n d Ve g e t a b l e s
6 . 3 . 2 . 3 D a i r y - b a s e d P r o d u c t s
6 . 3 . 2 . 4 P r o b i o t i c s a n d P r e b i o t i c s
6 . 3 . 2 . 5 O th e r s
6 . 3 . 3 M a r k e t F o r e c a s t
6 . 4 O th e r s
6 . 4 . 1 M a r k e t T r e n d s
6 . 4 . 2 M a r k e t F o r e c a s t
7 M a r k e t B r e a k u p b y D i s t r i b u t i o n C h a n n e l
7 . 1 C o n v e n i e n c e S t o r e s
7 . 1 . 1 M a r k e t T r e n d s
7 . 1 . 2 M a r k e t F o r e c a s t
Table of 7 . 2 M e d i c a l S t o r e s 7 . 2 . 1 M a r k e t T r e n d s
7 . 2 . 2 M a r k e t F o r e c a s t
Contents 7 . 3 S u p e r m a r k e t s a n d H y p e r m a r k e t s 7 . 3 . 1 M a r k e t T r e n d s
7 . 3 . 2 M a r k e t F o r e c a s t
7 . 4 O n l i n e S to r e s
7 . 4 . 1 M a r k e t T r e n d s
7 . 4 . 2 M a r k e t F o r e c a s t
7 . 5 O th e r s
7 . 5 . 1 M a r k e t T r e n d s
7 . 5 . 2 M a r k e t F o r e c a s t
8 M a r k e t B r e a k u p b y R e g i o n
8 . 1 N o r t h A m e r i c a
8 . 1 . 1 U n i t e d S t a te s
8 . 1 . 1 . 1 M a r k e t T r e n d s
8 . 1 . 1 . 2 M a r k e t F o r e c a s t
F o r m o r e i n f o r m a t io n , v i s i t :
ht tps : / /www. imarcgroup .com/ immuni ty-boost ing -produc ts -m
arket / toc
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024 IMARC Al l R ights Reserved
Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f
I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be
rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so
no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing ,
reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress
c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) .
Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion
have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f
pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f
war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC
accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r
i naccu rac ies i f any f ound th is pub l i ca t ion .
IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l
Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re
reg i s te red t rademarks o f t he i r r espec t i ve compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us:
Comments